AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
Adenovirus infections in adult recipients of blood and marrow transplants
Authors: La Rosa, AM Champlin, RE Mirza, N Gajewski, J Giralt, S Rolston, KV Raad, I Jacobson, K Kontoyiannis, D Elting, L Whimbey, E
Citation: Am. La Rosa et al., Adenovirus infections in adult recipients of blood and marrow transplants, CLIN INF D, 32(6), 2001, pp. 871-876
Impact of high-dose chemotherapy on peripheral T-cell lymphomas
Authors: Rodriguez, J Munsell, M Yazji, S Hagemeister, FB Younes, A Andersson, B Giralt, S Gajewski, J de Lima, M Couriel, D Romaguera, J Cobanillas, FF Champlin, RE Khouri, IF
Citation: J. Rodriguez et al., Impact of high-dose chemotherapy on peripheral T-cell lymphomas, J CL ONCOL, 19(17), 2001, pp. 3766-3770
Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins
Authors: Ghosh, S Champlin, RE Ueno, NT Anderlini, P Rolston, K Raad, I Kontoyiannis, D Jacobson, K Luna, M Tarrand, J Whimbey, E
Citation: S. Ghosh et al., Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins, BONE MAR TR, 28(3), 2001, pp. 271-275
Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients
Authors: Konoplev, S Champlin, RE Giralt, S Ueno, NT Khouri, I Raad, I Rolston, K Jacobson, K Tarrand, J Luna, M Nguyen, Q Whimbey, E
Citation: S. Konoplev et al., Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients, BONE MAR TR, 27(8), 2001, pp. 877-881
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases
Authors: Anderlini, P Rizzo, JD Nugent, ML Schmitz, N Champlin, RE Horowitz, MM
Citation: P. Anderlini et al., Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases, BONE MAR TR, 27(7), 2001, pp. 689-692
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer
Authors: Donato, ML Gershenson, DM Wharton, JT Ippoliti, CM Aleman, AS Bodurka-Bevers, D Bevers, MW Burke, TW Levenback, CF Wolf, JK Freedman, RS Bast, RC Gajewski, JL Champlin, RE
Citation: Ml. Donato et al., High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer, GYNECOL ONC, 82(3), 2001, pp. 420-426
Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity
Authors: Gopal, R Ha, CS Tucker, SL Khouri, IF Giralt, SA Gajewski, JL Andersson, BS Cox, JD Champlin, RE
Citation: R. Gopal et al., Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity, CANCER, 92(7), 2001, pp. 1949-1958
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
Authors: Khouri, IF Saliba, RM Giralt, SA Lee, MS Okoroji, GJ Hagemeister, FB Korbling, M Younes, A Ippoliti, C Gajewski, JL McLaughlin, P Anderlini, P Donato, ML Cabanillas, FF Champlin, RE
Citation: If. Khouri et al., Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality, BLOOD, 98(13), 2001, pp. 3595-3599
High-dose chemotherapy as treatment for high-risk primary and metastatic breast cancer
Authors: Ueno, NT Champlin, RE
Citation: Nt. Ueno et Re. Champlin, High-dose chemotherapy as treatment for high-risk primary and metastatic breast cancer, MDA CANC CA, 2001, pp. 342-365
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
Authors: Hortobagyi, GN Buzdar, AU Theriault, RL Valero, V Frye, D Booser, DJ Holmes, FA Giralt, S Khouri, I Andersson, B Gajewski, JL Rondon, G Smith, TL Singletary, SE Ames, FC Sneige, N Strom, EA McNeese, MD Deisseroth, AB Champlin, RE
Citation: Gn. Hortobagyi et al., Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma, J NAT CANC, 92(3), 2000, pp. 225-233
Acute safety and pharmacokinetics of intravenous busulfan when used with oval busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study
Authors: Andersson, BS Madden, T Tran, HT Hu, WW Blume, KG Chow, DSL Champlin, RE Vaughan, WP
Citation: Bs. Andersson et al., Acute safety and pharmacokinetics of intravenous busulfan when used with oval busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study, BIOL BLOOD, 6(5A), 2000, pp. 548-554
Status of high-dose chemotherapy for breast cancer: A review
Authors: Nieto, Y Champlin, RE Wingard, JR Vredenburgh, JJ Elias, AD Richardson, PR Glaspy, J Jones, RB Stiff, PJ Bearman, SI Cagnoni, PJ McSweeney, PA LeMaistre, CF Pecora, AL Shpall, EJ
Citation: Y. Nieto et al., Status of high-dose chemotherapy for breast cancer: A review, BIOL BLOOD, 6(5), 2000, pp. 476-495
Evidence that specific T lymphocytes may participate in the elimination ofchronic myelogenous leukemia
Authors: Molldrem, JJ Lee, PP Wang, CQ Felio, K Kantarjian, HM Champlin, RE Davis, MM
Citation: Jj. Molldrem et al., Evidence that specific T lymphocytes may participate in the elimination ofchronic myelogenous leukemia, NAT MED, 6(9), 2000, pp. 1018-1023
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation
Authors: Couriel, DR Hicks, K Giralt, S Champlin, RE
Citation: Dr. Couriel et al., Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation, CURR OPIN O, 12(6), 2000, pp. 582-587
Management of cancer treatment-related diarrhea: Issues and therapeutic strategies
Authors: Kornblau, S Benson, AB Catalano, R Champlin, RE Engelking, C Field, M Ippoliti, C Lazarus, HM Mitchell, E Rubin, J Stiff, PJ Vokes, E Wadler, S
Citation: S. Kornblau et al., Management of cancer treatment-related diarrhea: Issues and therapeutic strategies, J PAIN SYMP, 19(2), 2000, pp. 118-129
Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia
Authors: Seong, CM Giralt, S Kantarjian, H Xu, JP Swantkowski, J Hayes, K Glassman, AB Khouri, I Korbling, M Thall, P Siciliano, MJ Champlin, RE
Citation: Cm. Seong et al., Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia, J CL ONCOL, 18(9), 2000, pp. 1831-1836
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer
Authors: Donato, ML Champlin, RE Wharton, JT Bodurka-Bevers, D Gershenson, D
Citation: Ml. Donato et al., Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer, EUR J GYN O, 21(3), 2000, pp. 241-244
Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant
Authors: Buchholz, TA Tucker, SL Moore, RA McNeese, MD Strom, EA Jhingrin, A Hortobagyi, GN Singletary, SE Champlin, RE
Citation: Ta. Buchholz et al., Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant, INT J RAD O, 46(2), 2000, pp. 337-343
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease
Authors: Anderlini, P Giralt, S Andersson, B Ueno, NT Khouri, I Acholonu, S Cohen, A Korbling, MJ Manning, J Romaguera, J Sarris, A Rodriguez, MA Hagemeister, F McLaughlin, P Cabanillas, F Champlin, RE
Citation: P. Anderlini et al., Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease, BONE MAR TR, 26(6), 2000, pp. 615-620
Bronchoalveolar lavage in the diagnosis of pulmonary complications of bonemarrow transplant patients
Authors: Huaringa, AJ Leyva, FJ Signes-Costa, J Morice, RC Raad, I Darwish, AA Champlin, RE
Citation: Aj. Huaringa et al., Bronchoalveolar lavage in the diagnosis of pulmonary complications of bonemarrow transplant patients, BONE MAR TR, 25(9), 2000, pp. 975-979
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin
Authors: Ghosh, S Champlin, RE Englund, J Giralt, SA Rolston, K Raad, I Jacobson, K Neumann, J Ippoliti, C Mallik, S Whimbey, E
Citation: S. Ghosh et al., Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin, BONE MAR TR, 25(7), 2000, pp. 751-755
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)
Authors: Andersson, BS Gajewski, J Donato, M Giralt, S Gian, V Wingard, J Tarantolo, S Fernandez, H Hu, WW Blume, K Kashyap, A Forman, SJ Champlin, RE
Citation: Bs. Andersson et al., Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy), BONE MAR TR, 25, 2000, pp. S35-S38
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer
Authors: Donato, ML Gershenson, D Ippoliti, C Wharton, JT Bast, RC Aleman, A Anderlini, P Gajewski, JG Giralt, S Molldrem, J Ueno, N Lauppe, J Korbling, M Boyer, J Bodurka-Bevers, D Bevers, M Burke, T Freedman, R Levenback, C Wolf, J Champlin, RE
Citation: Ml. Donato et al., High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer, BONE MAR TR, 25(11), 2000, pp. 1137-1140
Outcome of bone marrow transplantation patients requiring mechanical ventilation
Authors: Huaringa, AJ Leyva, FJ Giralt, SA Blanco, J Signes-Costa, J Velarde, H Champlin, RE
Citation: Aj. Huaringa et al., Outcome of bone marrow transplantation patients requiring mechanical ventilation, CRIT CARE M, 28(4), 2000, pp. 1014-1017
Allogeneic haematopoietic transplantation for Richter's syndrome
Authors: Rodriguez, J Keating, MJ O'Brien, S Champlin, RE Khouri, IF
Citation: J. Rodriguez et al., Allogeneic haematopoietic transplantation for Richter's syndrome, BR J HAEM, 110(4), 2000, pp. 897-899
Risultati: 1-25 | 26-34